secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0000950170-25-074446
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders re-elect three Class I directors, ratify KPMG, and approve executive compensation on advisory basis
--------------------------------------------------------------------------------

- Elected three Class I directors (Fordyce, Seidenberg, Hall) each with >49M votes for, ~5.4M withheld, and 1.8M broker non-votes.
- Ratified KPMG LLP as auditor for FY2025 with 56.6M votes for and only 3,556 against.
- Advisory 'Say-on-Pay' approved with 52.98M votes for (96.6% of votes cast).
- Stockholders recommended annual advisory vote on executive compensation (54.8M votes for 'One Year'); company to hold annual votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000095017025074446/0000950170-25-074446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000095017025074446/vera-20250514.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-074446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer